Report Library
View More
Datamonitor Healthcare CV&Met Disea...
December 9, 2022
Datamonitor Healthcare CV&Met Disea...
December 9, 2022
Datamonitor Healthcare Oncology: Pa...
December 9, 2022
Datamonitor Healthcare Oncology: Ga...
December 9, 2022
Datamonitor Healthcare Other: Polyc...
December 8, 2022
Datamonitor Healthcare I&I: Irritab...
December 8, 2022
Datamonitor Healthcare Oncology Dis...
December 7, 2022
Datamonitor Healthcare Infectious D...
December 7, 2022
Datamonitor Healthcare CV&Met: Atri...
December 7, 2022
Datamonitor Healthcare Other: Uteri...
December 7, 2022
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 12/9/22 | Cytokinetics (CYTK) | Omecamtiv Mecarbil (Oral) for Chronic Heart Failure - Reduced Ejection Fraction (Chronic HFrEF) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/7/22 | Esperion Therapeutics (ESPR) | Nexletol for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/6/22 | Idorsia (IDIA) | NBI-827104 for Partial Seizures (Epilepsy) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/6/22 | Gossamer Bio (GOSS) | GB002 for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/6/22 | Editas (EDIT) | EDIT-301 for Sickle Cell Anemia | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 12/08/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 12/08/22 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 12/08/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 12/08/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 12/08/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
